212 related articles for article (PubMed ID: 36598557)
1. Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology.
Glasson Y; Chépeaux LA; Dumé AS; Lafont V; Faget J; Bonnefoy N; Michaud HA
Semin Immunopathol; 2023 Jan; 45(1):17-28. PubMed ID: 36598557
[TBL] [Abstract][Full Text] [Related]
2. A 31-plex panel for high-dimensional single-cell analysis of murine preclinical models of solid tumors by imaging mass cytometry.
Glasson Y; Chépeaux LA; Dumé AS; Jay P; Pirot N; Bonnefoy N; Michaud HA
Front Immunol; 2022; 13():1011617. PubMed ID: 36741363
[TBL] [Abstract][Full Text] [Related]
3. Imaging mass cytometry: High-dimensional and single-cell perspectives on the microenvironment of solid tumours.
Liu Z; Xun J; Liu S; Wang B; Zhang A; Zhang L; Wang X; Zhang Q
Prog Biophys Mol Biol; 2022 Nov; 175():140-146. PubMed ID: 36252872
[TBL] [Abstract][Full Text] [Related]
4. High Dimensional Imaging Mass Cytometry Panel to Visualize the Tumor Immune Microenvironment Contexture.
Elaldi R; Hemon P; Petti L; Cosson E; Desrues B; Sudaka A; Poissonnet G; Van Obberghen-Schilling E; Pers JO; Braud VM; Anjuère F; Meghraoui-Kheddar A
Front Immunol; 2021; 12():666233. PubMed ID: 33936105
[TBL] [Abstract][Full Text] [Related]
5. Application of High-Throughput Imaging Mass Cytometry Hyperion in Cancer Research.
Le Rochais M; Hemon P; Pers JO; Uguen A
Front Immunol; 2022; 13():859414. PubMed ID: 35432353
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment.
Kuett L; Catena R; Özcan A; Plüss A; ; Schraml P; Moch H; de Souza N; Bodenmiller B
Nat Cancer; 2022 Jan; 3(1):122-133. PubMed ID: 35121992
[TBL] [Abstract][Full Text] [Related]
7. Beyond the message: advantages of snapshot proteomics with single-cell mass cytometry in solid tumors.
Mistry AM; Greenplate AR; Ihrie RA; Irish JM
FEBS J; 2019 Apr; 286(8):1523-1539. PubMed ID: 30549207
[TBL] [Abstract][Full Text] [Related]
8. Mass Cytometry Imaging for the Study of Human Diseases-Applications and Data Analysis Strategies.
Baharlou H; Canete NP; Cunningham AL; Harman AN; Patrick E
Front Immunol; 2019; 10():2657. PubMed ID: 31798587
[TBL] [Abstract][Full Text] [Related]
9. Spatially mapping the immune landscape of melanoma using imaging mass cytometry.
Moldoveanu D; Ramsay L; Lajoie M; Anderson-Trocme L; Lingrand M; Berry D; Perus LJM; Wei Y; Moraes C; Alkallas R; Rajkumar S; Zuo D; Dankner M; Xu EH; Bertos NR; Najafabadi HS; Gravel S; Costantino S; Richer MJ; Lund AW; Del Rincon SV; Spatz A; Miller WH; Jamal R; Lapointe R; Mes-Masson AM; Turcotte S; Petrecca K; Dumitra S; Meguerditchian AN; Richardson K; Tremblay F; Wang B; Chergui M; Guiot MC; Watters K; Stagg J; Quail DF; Mihalcioiu C; Meterissian S; Watson IR
Sci Immunol; 2022 Apr; 7(70):eabi5072. PubMed ID: 35363543
[TBL] [Abstract][Full Text] [Related]
10. A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry.
Ijsselsteijn ME; van der Breggen R; Farina Sarasqueta A; Koning F; de Miranda NFCC
Front Immunol; 2019; 10():2534. PubMed ID: 31736961
[TBL] [Abstract][Full Text] [Related]
11. Imaging Mass Cytometry in Immuno-Oncology.
Cotechini T; Jones O; Hindmarch CCT
Methods Mol Biol; 2023; 2614():1-15. PubMed ID: 36587115
[TBL] [Abstract][Full Text] [Related]
12. Mass cytometry to characterize the immune lung cancer microenvironment.
Badri T; Eguren-Santamaria I; Fernandez-Pierola E; Sanmamed MF
Methods Cell Biol; 2023; 174():31-41. PubMed ID: 36710049
[TBL] [Abstract][Full Text] [Related]
13. Robust Cell Detection and Segmentation for Image Cytometry Reveal Th17 Cell Heterogeneity.
Tsujikawa T; Thibault G; Azimi V; Sivagnanam S; Banik G; Means C; Kawashima R; Clayburgh DR; Gray JW; Coussens LM; Chang YH
Cytometry A; 2019 Apr; 95(4):389-398. PubMed ID: 30714674
[TBL] [Abstract][Full Text] [Related]
14. MATISSE: a method for improved single cell segmentation in imaging mass cytometry.
Baars MJD; Sinha N; Amini M; Pieterman-Bos A; van Dam S; Ganpat MMP; Laclé MM; Oldenburg B; Vercoulen Y
BMC Biol; 2021 May; 19(1):99. PubMed ID: 33975602
[TBL] [Abstract][Full Text] [Related]
15. TITAN: An end-to-end data analysis environment for the Hyperion™ imaging system.
Thirumal S; Jamzad A; Cotechini T; Hindmarch CT; Graham CH; Siemens DR; Mousavi P
Cytometry A; 2022 May; 101(5):423-433. PubMed ID: 35060322
[TBL] [Abstract][Full Text] [Related]
16. Imaging Mass Cytometry for In Situ Immune Profiling.
Hu K; Harman A; Baharlou H
Methods Mol Biol; 2024; 2779():407-423. PubMed ID: 38526797
[TBL] [Abstract][Full Text] [Related]
17. Imaging Mass Cytometry.
Chang Q; Ornatsky OI; Siddiqui I; Loboda A; Baranov VI; Hedley DW
Cytometry A; 2017 Feb; 91(2):160-169. PubMed ID: 28160444
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of Imaging Mass Cytometry to Explore the Single Cell Alloimmune Landscape of Liver Transplant Rejection.
Ung N; Goldbeck C; Man C; Hoeflich J; Sun R; Barbetta A; Matasci N; Katz J; Lee JSH; Chopra S; Asgharzadeh S; Warren M; Sher L; Kohli R; Akbari O; Genyk Y; Emamaullee J
Front Immunol; 2022; 13():831103. PubMed ID: 35432320
[TBL] [Abstract][Full Text] [Related]
19. Biomarker Discovery in Patients with Immunotherapy-Treated Melanoma with Imaging Mass Cytometry.
Martinez-Morilla S; Villarroel-Espindola F; Wong PF; Toki MI; Aung TN; Pelekanou V; Bourke-Martin B; Schalper KA; Kluger HM; Rimm DL
Clin Cancer Res; 2021 Apr; 27(7):1987-1996. PubMed ID: 33504554
[TBL] [Abstract][Full Text] [Related]
20. High-resolution 3D visualization of nanomedicine distribution in tumors.
Moss JI; Barjat H; Emmas SA; Strittmatter N; Maynard J; Goodwin RJA; Storm G; Lammers T; Puri S; Ashford MB; Barry ST
Theranostics; 2020; 10(2):880-897. PubMed ID: 31903157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
